Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Ursodeoxycholic Acid as a Biliary Agent Used in the Treatment of Liver Disease: An Overview


Affiliations
1 P. Wadhwani College of Pharmacy, Yavatmal - 445001, India
     

   Subscribe/Renew Journal


Ursodeoxycholic acid is a dihydroxy bile acid with a rapidly expanding spectrum of usage in acute and chronic liver diseases. The various mechanisms of action of this hydrophilic bile acid include direct cytoprotection, detergent action on dysfunctional microtubules, immunomodulation and induction of hypercholeresis.

 

Its efficacy in primary biliary cirrhosis and primary sclerosing cholangitis as an adjunct to medical therapy has been well established. Newer indications include its use in the management of chronic hepatitis, cirrhosis, post liver transplant rejection, graft versus-host disease and acute viral hepatitis, where it not only relieves symptoms of holestasis but also arrests ongoing hepatocyte necrosis.

Keywords

Biliary Cirrhosis, Primary Sclerosing Cholangitis, Ursodeoxycholic Acid.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Arch Intern Med. 1999; 159:2647-2658.

  • http://www.patient.co.uk/

  • http://www.drugbank.ca/

  • Merk index, 8th Edn. , P.1098

  • Physician desk reference-61, 2007, P.710-71

  • Martin dale, 35th Edn., vol.I, P.No.2057, 2182

  • European pharmacopoeia, 9th Edn., vol.I, P.416

  • British pharmacopeia 2005, vol. III, p..5856-2858

  • Wikipedia, the free encyclopedia.mht

  • Digestive Diseases A-Z List of Topics and Titles : Gallstones, www.google.com

  • Postgrad Med J 1997; 73: 75-80

  • Medisafe newz eland medicines and medical devices safty authority a business unit of ministry of health.


Abstract Views: 292

PDF Views: 1




  • Ursodeoxycholic Acid as a Biliary Agent Used in the Treatment of Liver Disease: An Overview

Abstract Views: 292  |  PDF Views: 1

Authors

S. B. Gaikwad
P. Wadhwani College of Pharmacy, Yavatmal - 445001, India
R. L. Bakal
P. Wadhwani College of Pharmacy, Yavatmal - 445001, India
A. V. Chandewar
P. Wadhwani College of Pharmacy, Yavatmal - 445001, India
A. B. Roge
P. Wadhwani College of Pharmacy, Yavatmal - 445001, India
R. S. Sakhare
P. Wadhwani College of Pharmacy, Yavatmal - 445001, India
S. G. Shep
P. Wadhwani College of Pharmacy, Yavatmal - 445001, India

Abstract


Ursodeoxycholic acid is a dihydroxy bile acid with a rapidly expanding spectrum of usage in acute and chronic liver diseases. The various mechanisms of action of this hydrophilic bile acid include direct cytoprotection, detergent action on dysfunctional microtubules, immunomodulation and induction of hypercholeresis.

 

Its efficacy in primary biliary cirrhosis and primary sclerosing cholangitis as an adjunct to medical therapy has been well established. Newer indications include its use in the management of chronic hepatitis, cirrhosis, post liver transplant rejection, graft versus-host disease and acute viral hepatitis, where it not only relieves symptoms of holestasis but also arrests ongoing hepatocyte necrosis.

Keywords


Biliary Cirrhosis, Primary Sclerosing Cholangitis, Ursodeoxycholic Acid.

References